Orange, CANCT05600842Now EnrollingIRB Ready

HPV Positive Oropharyngeal Squamous Cell Carcinoma Clinical Trial in Orange, CA

Access cutting-edge hpv positive oropharyngeal squamous cell carcinoma treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.

Sponsored by University of California, Irvine

Quick Self-Assessment

See if you qualify for this Orange location

Preparing your pre-screening questions…

Expert Care in Orange

Access hpv positive oropharyngeal squamous cell carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hpv positive oropharyngeal squamous cell carcinoma treatment provided free

Apply for This Orange Location

Check if you qualify for this hpv positive oropharyngeal squamous cell carcinoma clinical trial in Orange, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Orange

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Orange site if eligible
  4. 4Begin participation

About This HPV Positive Oropharyngeal Squamous Cell Carcinoma Study in Orange

This is a single-arm, observational registry study determining the effects of reduced radiation dose in select patients with human papillomavirus (HPV) positive oropharyngeal cancer.

Sponsor: University of California, Irvine

Who Can Participate

Inclusion Criteria

Pathologically (histologically or cytologically) proven (from primary lesion and/or lymph nodes) diagnosis of human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma. HPV-positivity will be defined as tumors that are p16-positive by immunohistochemistry. Numerous studies have demonstrated near 100% agreement between p16 and HPV for patients with oropharyngeal cancer. As such, the use of p16 has been accepted as an appropriate surrogate for HPV status.
Clinical stage I, II, or III disease (AJCC Eighth Edition); Note: Patients with M1 tumors (distant metastases) are not eligible;
History/physical examination within 6 weeks prior to registration, including assessment of weight and recent weight loss;
PET/CT within 6 weeks prior to registration;
Patients must sign a study-specific informed consent form prior to study entry.
Both men and women and members of all races and ethnic groups are eligible for this trial. Non-English speaking, deaf, hard of hearing and illiterate individuals are eligible for this trial.

Exclusion Criteria

Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years;
Patients who have had initial surgical treatment other than the diagnostic biopsy of the primary site or nodal sampling of the neck disease are excluded;
Prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a different cancer is allowable;
Receipt of prior radiotherapy that would result in overlap with proposed field.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Orange?

Yes, this clinical trial (NCT05600842) has an active research site in Orange, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HPV Positive Oropharyngeal Squamous Cell Carcinoma Treatment Options in Orange, CA

If you're searching for hpv positive oropharyngeal squamous cell carcinoma treatment options in Orange, CA, this clinical trial (NCT05600842) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hpv positive oropharyngeal squamous cell carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hpv positive oropharyngeal squamous cell carcinoma clinical trials near you to find additional studies recruiting in your area.

More Head and Neck Cancer Trials in Orange, CA

See all head and neck cancer clinical trials recruiting in Orange — not just this study.

Browse Head and Neck Cancer Trials in Orange →

Browse More Trials by Condition

Head and Neck Cancer TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Orange?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Orange, CA